Liver News and Research

RSS

Aspirin might well be considered the top utility player in the medicine cabinet

This cheap over-the-counter drug can be used not only for fever, pain and arthritis, but to prevent heart attack, stroke or angina. It also may reduce the risk of colorectal cancer. Yet aspirin also has side effects worth considering, and its very accessibility may hamper its use.

8 Oct 2004

Interleukin-6 has potential as a therapeutic drug in treating metabolic disorders such as obesity, type 2 diabetes and atherosclerosis

For the most of the past century, researchers have searched for a muscle-contraction-induced factor, which mediates some of the exercise effects in other tissues and organs such as the liver and adipose tissue.

5 Oct 2004

Short-term exercise significantly increases insulin action

Carefully controlling the amount of food and drink that formerly sedentary, overweight people ingest during and after short-term exercise has a significant impact on insulin action.

5 Oct 2004

Teva Pharmaceuticals granted final approval for Ribavirin capsules

Teva Pharmaceutical Industries has announced that the U.S. Food and Drug Administration has granted final approval for the Company’s ANDA for Ribavirin Capsules, 200 mg. Shipment of this product is expected to begin immediately.

5 Oct 2004

Patent pending discovery could help type 2 diabetics

Scientists from MitoChroma Research have recently announced a patent-pending discovery that could complement current medical management modalities for Type 2 Diabetes, insulin resistance and the set of related conditions called "Metabolic Syndrome."

4 Oct 2004

Prognostic factors influencing survival in patients with brain metastases identified

Allos Therapeutics has announced the presentation of new findings from its Phase 3 clinical trial of the investigational radiation sensitizer Efaproxyn (efaproxiral) in patients with brain metastases.

4 Oct 2004

$75 million over 5 years to study islet transplantation in patients with type 1 diabetes

The National Institutes of Health (NIH) announced today that it plans to award about $75 million over five years to five clinical centers and a data coordinating center to conduct studies of islet transplantation in patients with type 1 diabetes.

4 Oct 2004

3 year study to validate bladder cancer test

A three-year study to validate a test to detect the recurrence of bladder cancer has been initiated by the National Cancer Institute (NCI), at 12 centers across the United States and Canada.

4 Oct 2004

Vitamin supplements not effective in protecting against gastro-intestinal cancer

A systematic review and meta-analysis (pooled analysis) of previously published randomised trials in this week’s issue of THE LANCET provides strong evidence that antioxidant supplements (such as vitamin supplements) are not effective in protecting against gastro-intestinal cancer.

30 Sep 2004

Antiretroviral treatment may provide protection against HIV transmission during breast-feeding

Women who take combination AIDS drugs not only have benefits for their own health but also may pass along high levels of the medication through breast-feeding, potentially protecting their infants from HIV infection

30 Sep 2004

Cancer vaccine based on listeria bacteria shows promise

An experimental cancer vaccine using defanged listeria bacteria is showing great promise in animal studies, successfully treating new cancers that have spread into the lungs of mice.

29 Sep 2004

Two new cases of leptospirosis confirmed in Hong Kong

Hong Kong's Centre for Health Protection (CHP) of the Department of Health has confirmed two new cases of leptospirosis involving participants of the hiking activity "Team Challenge 36" held in August.

28 Sep 2004

Low-dose infusion of ketamine completely relieves pain of complex regional pain syndrome

Limited, low-dose infusions of a widely used anesthetic drug may relieve the often intolerable and debilitating pain of Complex Regional Pain Syndrome (CRPS), a Penn State Milton S. Hershey Medical Center researcher found.

23 Sep 2004

New combination of drugs results in fewer incidences of rejection in liver transplant patients

“The big advantage [of this combination of drugs] is that the incidence of rejection is significantly decreased,” he says. “These results could change the standard of care for liver transplant recipients.”

23 Sep 2004

Research to halt the progress of chronic liver disease

A University of Queensland researcher is working to halt the progress of chronic liver disease, which affects a quarter of million Australians.

22 Sep 2004

Slimming products may cause health risk

Hong Kong's Department of Health has called on people not to buy or take health products for slimming purpose without proper advice from their family doctors or Chinese medicine practitioners.

22 Sep 2004

Non-human primates should never be considered as source animals for any future clinical trials of animal-to-human transplantation

Australia’s leading health advisory body, the National Health and Medical Research Council, says there should be a five-year moratorium on any clinical research into animal-to-human whole organ transplants in Australia.

20 Sep 2004

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to increase

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to kill people in the prime of life and burden health systems with chronically sick people unless childhood immunization against hepatitis B is stepped up

20 Sep 2004

Liver cancer genes cluster into two subsets that correlate to survival

An analysis of the gene expression patterns of 91 unrelated liver tumors revealed two distinctive subclasses highly associated with patient survival, according to a new study published in the September 2004 issue of Hepatology.

14 Sep 2004

Hibiscus flowers contain antioxidants that help control cholesterol levels

Hibiscus flower extract may have the same health benefits as red wine and tea according to new research by scientists in Taiwan. Hibiscus contains antioxidants that help control cholesterol levels and reduce heart disease, says the research in Journal of the Science of Food and Agriculture.

14 Sep 2004

Liver News and Research

Aspirin might well be considered the top utility player in the medicine cabinet

Interleukin-6 has potential as a therapeutic drug in treating metabolic disorders such as obesity, type 2 diabetes and atherosclerosis

Short-term exercise significantly increases insulin action

Teva Pharmaceuticals granted final approval for Ribavirin capsules

Patent pending discovery could help type 2 diabetics

Prognostic factors influencing survival in patients with brain metastases identified

$75 million over 5 years to study islet transplantation in patients with type 1 diabetes

3 year study to validate bladder cancer test

Vitamin supplements not effective in protecting against gastro-intestinal cancer

Antiretroviral treatment may provide protection against HIV transmission during breast-feeding

Cancer vaccine based on listeria bacteria shows promise

Two new cases of leptospirosis confirmed in Hong Kong

Low-dose infusion of ketamine completely relieves pain of complex regional pain syndrome

New combination of drugs results in fewer incidences of rejection in liver transplant patients

Research to halt the progress of chronic liver disease

Slimming products may cause health risk

Non-human primates should never be considered as source animals for any future clinical trials of animal-to-human transplantation

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to increase

Liver cancer genes cluster into two subsets that correlate to survival

Hibiscus flowers contain antioxidants that help control cholesterol levels

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News